SAN FRANCISCO (Thomson Financial) - Orthovita Inc. late Wednesday reported a
fourth-quarter net loss of $4.85 million, or 6 cents a share, compared with a
net loss of $4.34 million, or 8 cents a share, during the year earlier.
There were 75.1 million shares outstanding in the latest quarter versus 56.3
million a year ago.
Excluding charges related to the tender offer and stock options, the loss
decreased to $3.7 million from $4.2 million.
The Malvern, Pa.-based company posted product sales for the three months
ended Dec. 31 of $15.6 million versus $13.8 million last year.
The mean estimate of analysts polled by Thomson Financial was for a
per-share loss of 3 cents on revenue of $16.2 million.
Shares of the spine and orthopedic biosurgery company closed the regular
session down 12 cents, or 4.6%, at $2.48.
Katherine Hunt
kh
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|